2023 was a troublesome year for the biopharma industry, with quite a few corporations downsizing and restructuring their workforces to stay afloat. You will find indications of Restoration, as mergers and acquisitions picked up through the pharmaceutical and life sciences field inside the latter Element of 2023 and have ongoing https://sites.google.com/view/bio-sites/blog